Fluoride therapy for the vertebral crush fracture syndrome. A status report

R. P. Heaney, D. J. Baylink, C. C. Johnston, L. J. Melton, P. J. Meunier, T. M. Murray, C. Nagant de Deuxchaisnes

Research output: Contribution to journalArticlepeer-review

58 Scopus citations


Fluoride has been proposed as a therapy for the vertebral crush fracture syndrome for many years; such proposals have been based largely on the well-characterized syndrome of fluoride intoxication (fluorosis), which is marked by increased skeletal mass and sometimes exuberant bony overgrowths. For various reasons, including the inability to develop a patentable product, the clinical studies necessary to follow this lead and establish efficacy and safety have proceeded slowly. This report represents points of concurrent regarding the efficacy and safety of fluoride therapy and considerations relevant to patient management that were developed among conferees at the International Workshop on Fluoride and Bone.

Original languageEnglish (US)
Pages (from-to)678-680
Number of pages3
JournalAnnals of internal medicine
Issue number8
StatePublished - 1989

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Fluoride therapy for the vertebral crush fracture syndrome. A status report'. Together they form a unique fingerprint.

Cite this